Stock Report

All about this stock under one free report Last Updated: 30-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

Novelix Pharmaceuticals Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

BSE: 536565

₹81.90

up-down-arrow ₹1.40 (1.74%)

As on 28-Aug-2026IST

Market cap

info icon

₹233 Cr

Revenue (TTM)

info icon

₹147 Cr

P/E Ratio

info icon

64.2

P/B Ratio

info icon

3.7

Div. Yield

info icon

0 %

Edit peer-selector-edit
Novelix Pharmaceuticals JB Chemicals Pfizer Caplin Point Lab Eris Lifesciences
Market cap (₹ Cr)
 233 38,731 21,501 19,125 18,253
Revenue (₹ Cr)
 147 4,148 2,570 2,287 3,230
Net Profit (₹ Cr)
 3.63 709.47 735.15 678.07 666.92
Net Margin (%)
 2.47 16.85 26.88 28.10 20.60
RoE (%)
 10.07 19.11 19.16 19.73 18.75
Price to Earnings
 64.23 54.59 29.25 28.74 28.35
Price-To-Book
 3.67 9.31 4.88 5.08 4.51

Income Statement (₹ Cr)

Novelix Pharmaceuticals JB Chemicals Pfizer Caplin Point Lab Eris Lifesciences
Operating Revenue arrow
30.72 3,917.99 2,281.35 1,937.47 2,893.64
Total Income arrow
30.73 3,957.03 2,453.60 2,033.90 2,912.00
Total Expenditure arrow
30.57 2,886.87 1,541.03 1,290.54 1,876.44
EBITDA arrow
0.15 1,031.12 740.32 646.93 1,017.20
Depreciation arrow
0.04 171.04 60.79 65.96 315.46
EBIT arrow
0.11 860.08 679.53 580.97 701.74
Interest arrow
0.00 11.73 8.50 0.61 231.29
Other Income arrow
0.02 39.04 172.25 96.43 18.36
Exceptional Items arrow
-- -- 172.81 -- --
Profit before Tax arrow
0.12 887.39 1,016.09 676.78 488.87
Provision for Tax arrow
0.04 227.81 248.49 135.69 114.20
Profit after Tax arrow
0.08 659.58 767.60 541.09 374.67

Liabilities (₹ Cr)

Novelix Pharmaceuticals JB Chemicals Pfizer Caplin Point Lab Eris Lifesciences
Shareholder's Funds arrow
17.54 3,433.32 4,217.41 2,850.49 2,854.36
Minority Interest arrow
-- -- -- 35.90 417.40
Non-Current Liabilities arrow
-0.04 443.23 54.89 13.24 2,100.97
Current Liabilities arrow
9.67 1,156.93 569.51 305.99 1,489.55
Total Liabilities arrow
27.21 5,033.48 4,911.11 3,207.85 6,862.28

Assets (₹ Cr)

Novelix Pharmaceuticals JB Chemicals Pfizer Caplin Point Lab Eris Lifesciences
Non-Current Assets arrow
0.23 2,586.15 1,328.96 1,071.67 5,531.13
Current Assets arrow
26.93 2,447.33 3,512.85 2,133.95 1,331.15
Total Assets arrow
27.21 5,033.48 4,911.11 3,207.85 6,862.28
Total Debt* arrow
0.00 13.80 2.50 0.55 2,421.66
Net Current Assets arrow
17.27 1,290.40 2,943.34 1,827.96 -158.40
Contingent Liabilities arrow
-- 131.94 363.79 0.64 64.29

Cashflow (₹ Cr)

Novelix Pharmaceuticals JB Chemicals Pfizer Caplin Point Lab Eris Lifesciences
Cash From Operating Activities arrow
-13.68 902.45 659.75 432.37 1,065.01
Cash Flow from Investing Activities arrow
2.93 -295.90 -71.34 -334.73 -79.97
Cash from Financing Activities arrow
11.32 -579.67 -205.34 -38.32 -881.32
Net Cash Inflow / Outflow arrow
0.56 26.88 383.07 59.32 103.72

Ratios

Profitability Ratios

 Novelix Pharmaceuticals JB Chemicals Pfizer Caplin Point Lab Eris Lifesciences
ROCE (%) arrow
1.00 26.73 26.21 26.22 13.59
ROE (%) arrow
0.68 21.81 19.65 21.72 13.81
ROA (%) arrow
0.49 13.58 17.03 18.37 5.48
EBIT Margin (%) arrow
0.53 27.31 40.00 38.37 35.79
Net Margin (%) arrow
0.28 16.67 31.28 26.60 12.87
Cash Profit Margin (%) arrow
0.40 20.46 34.70 31.33 23.22

Growth Ratios

 Novelix Pharmaceuticals JB Chemicals Pfizer Caplin Point Lab Eris Lifesciences
Revenue Growth (%) arrow
627.27 12.45 4.02 14.37 44.02
EBIT Growth (%) arrow
166.83 14.56 11.86 20.21 48.22
Net Profit Growth (%) arrow
711.76 19.35 39.23 17.27 -5.65
EPS Growth (%) arrow
558.14 18.98 39.23 17.25 -10.39
Book Value Growth (%) arrow
138.48 17.31 17.30 23.77 10.19

Valuation Ratios

 Novelix Pharmaceuticals JB Chemicals Pfizer Caplin Point Lab Eris Lifesciences
Price / Earnings arrow
313.43 38.29 23.86 28.38 54.83
Price / Book Value arrow
1.51 7.73 4.34 5.52 6.78
Dividend Yield (%) arrow
0.00 0.96 4.12 0.30 0.52
EV/EBITDA arrow
159.27 23.49 17.01 19.78 20.75
Market Cap (₹ Cr) arrow
26.48 25,253.79 18,318.10 15,219.80 19,292.77

Solvency Ratios

 Novelix Pharmaceuticals JB Chemicals Pfizer Caplin Point Lab Eris Lifesciences
Debt to Equity arrow
0.00 0.00 0.00 0.00 0.85
Short term debt to equity ratio arrow
-- 0.00 0.00 0.00 0.14
Current Ratio arrow
2.79 2.12 6.17 6.97 0.89
Quick Ratio arrow
2.70 1.66 5.33 5.88 0.67
Interest Coverage arrow
192.23 76.66 120.54 1,110.48 3.11

Operating Efficiency Ratios

 Novelix Pharmaceuticals JB Chemicals Pfizer Caplin Point Lab Eris Lifesciences
Debtors to sales (%) arrow
59.04 20.81 8.46 32.65 15.85
Asset Turnover arrow
1.78 0.84 0.53 0.66 0.43
Receivable days arrow
107.83 67.54 29.10 110.70 54.07
Inventory Days arrow
12.11 46.37 69.53 65.86 32.16
Payable days arrow
57.42 106.33 76.77 105.88 140.91
Cash Conversion Cycle arrow
62.52 7.58 21.86 70.68 -54.68
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...